Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Intellia Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Intellia Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Intellia Therapeutics Inc addetti ai lavori?
A Intellia Therapeutics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori non hanno segnalato vendite negli ultimi 30 giorni, mentre gli addetti ai lavori hanno segnalato di aver acquistato un totale di 100.00K azioni per un valore totale di $1.00M.
Notevoli acquisti e vendite recenti di insider
- Il giorno agosto 22, 2025, WILLIAM CHASE, l'azienda - purchased 100K condivisioni per $10.03 ciascuna.
- Il giorno luglio 3, 2025, Eliana Clark, l'azienda EVP, CHIEF TECHNICAL OFFICER sold 1.02K condivisioni per $9.82 ciascuna.
- Il giorno luglio 3, 2025, Michael Dube, l'azienda VP, CHIEF ACCOUNTING OFFICER sold 2.5K condivisioni per $9.95 ciascuna.
Statistiche sulla proprietà per Intellia Therapeutics Inc
Numero di azioni emesse
107.347M
Azioni possedute dagli insider
3.384M
Percentuale posseduta dagli Insider
3.27%
Azioni possedute dagli investitori istituzionali
67.237M
Percentuale posseduta dagli investitori istituzionali
62.6%
Aug 22, 2025 | — | 100.00K | $10.03 | $1.00M | BUY | 288.24% | 134.69K | Aug 20 | ||
Jul 25, 2025 | EVP, CHIEF FINANCIAL OFFICER | -7.46K | $14.02 | -$104.62K | SELL | -6.57% | 106.06K | Jul 23 | ||
Jul 03, 2025 | EVP, CHIEF TECHNICAL OFFICER | -1.02K | $9.82 | -$10.04K | SELL | -1.06% | 95.37K | Jul 01 | ||
Jul 03, 2025 | VP, CHIEF ACCOUNTING OFFICER | -2.50K | $9.95 | -$24.90K | SELL | -4.20% | 57.14K | Jul 02 | ||
Jul 02, 2025 | — | -3.09K | $9.40 | -$29.07K | SELL | -11.27% | 24.36K | Jun 30 - Jul 01 | ||
May 01, 2025 | — | -265.00 | $8.50 | -$2.25K | SELL | -1.36% | 19.20K | Apr 29 | ||
Mar 04, 2025 | EVP, CHIEF TECHNICAL OFFICER | 31.32K | $8.99 | -$6.10K | GRANT | 48.90% | 95.37K | Mar 01 - Mar 04 | ||
Mar 04, 2025 | EVP, GENERAL COUNSEL | 37.43K | $8.99 | -$23.12K | GRANT | 50.24% | 111.92K | Mar 01 - Mar 04 | ||
Jan 31, 2025 | — | -265.00 | $9.97 | -$2.64K | SELL | -1.34% | 19.47K | Jan 29 | ||
Jan 07, 2025 | VP, CHIEF ACCOUNTING OFFICER | -1.37K | $12.18 | -$16.71K | SELL | -2.92% | 45.64K | Jan 03 | ||
Jan 07, 2025 | EVP, GENERAL COUNSEL | -7.07K | $12.18 | -$86.16K | SELL | -8.67% | 74.50K | Jan 03 | ||
Jan 07, 2025 | EVP, CHIEF MEDICAL OFFICER | -9.56K | $12.18 | -$116.40K | SELL | -9.83% | 87.67K | Jan 03 | ||
Jan 07, 2025 | EVP, CHIEF BUSINESS OFFICER | -6.50K | $12.18 | -$79.19K | SELL | -9.80% | 59.88K | Jan 03 | ||
Jan 07, 2025 | PRESIDENT AND CEO | -26.81K | $12.18 | -$326.51K | SELL | -2.61% | 999.53K | Jan 03 | ||
Jan 07, 2025 | EVP, CHIEF SCIENTIFIC OFFICER | -8.97K | $12.18 | -$109.21K | SELL | -10.38% | 77.39K | Jan 03 | ||
Jan 06, 2025 | EVP, CHIEF TECHNICAL OFFICER | -7.98K | $12.17 | -$97.09K | SELL | -11.08% | 64.05K | Jan 02 - Jan 03 | ||
Oct 04, 2024 | VP, CHIEF ACCOUNTING OFFICER | -2.01K | $19.01 | -$38.25K | SELL | -4.10% | 47.01K | Oct 02 | ||
Jul 03, 2024 | EVP, CHIEF TECHNICAL OFFICER | -405.00 | $22.93 | -$9.29K | SELL | -0.56% | 71.47K | Jul 01 | ||
Jun 20, 2024 | — | -1.50K | $25.00 | -$37.63K | SELL | -7.74% | 17.95K | Jun 17 | ||
Mar 05, 2024 | EVP, GENERAL COUNSEL | 30.10K | $32.99 | -$75.78K | GRANT | 58.47% | 81.57K | Mar 01 - Mar 04 | ||
Mar 05, 2024 | EVP, CHIEF TECHNICAL OFFICER | 30.63K | $32.99 | -$19.96K | GRANT | 74.98% | 71.47K | Mar 01 - Mar 04 | ||
Jan 10, 2024 | EVP, CHIEF SCIENTIFIC OFFICER | -2.27K | $28.87 | -$65.68K | SELL | -4.92% | 43.93K | Jan 08 | ||
Jan 05, 2024 | PRESIDENT AND CEO | -19.22K | $29.46 | -$566.31K | SELL | -2.08% | 904.90K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF MEDICAL OFFICER | -5.84K | $29.46 | -$172.13K | SELL | -9.70% | 54.37K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF SCIENTIFIC OFFICER | -5.53K | $29.46 | -$162.97K | SELL | -10.69% | 46.20K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF FINANCIAL OFFICER | -5.37K | $29.46 | -$158.05K | SELL | -11.68% | 40.59K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF BUSINESS OFFICER | -3.88K | $29.46 | -$114.22K | SELL | -9.49% | 36.99K | Jan 03 | ||
Jan 05, 2024 | EVP, GENERAL COUNSEL | -3.81K | $29.46 | -$112.10K | SELL | -6.88% | 51.47K | Jan 03 | ||
Jan 05, 2024 | EVP, CHIEF TECHNICAL OFFICER | -4.61K | $29.50 | -$135.95K | SELL | -10.14% | 40.84K | Jan 03 | ||
Nov 02, 2023 | DIRECTOR | -265.00 | $23.90 | -$6.33K | SELL | -2.16% | 12.00K | Oct 31 | ||
Aug 02, 2023 | DIRECTOR | -265.00 | $42.33 | -$11.22K | SELL | -2.12% | 12.26K | Jul 31 | ||
Jul 10, 2023 | DIRECTOR | -1.87K | $39.30 | -$73.37K | SELL | -12.97% | 12.53K | Jul 06 | ||
Jul 06, 2023 | EVP, CHIEF TECHNICAL OFFICER | -360.00 | $40.51 | -$14.58K | SELL | -0.79% | 45.15K | Jul 03 | ||
Jun 22, 2023 | EVP, CHIEF TECHNICAL OFFICER | 0.00 | $28.63 | -$163.65K | SELL-OPTIONS | 0.00% | 45.15K | Jun 20 | ||
Mar 03, 2023 | EVP, GENERAL COUNSEL | 35.72K | $43.88 | -$47.74K | GRANT | 182.63% | 55.28K | Mar 01 - Mar 02 | ||
Jan 06, 2023 | EVP, CHIEF SCIENTIFIC OFFICER | -4.84K | $37.82 | -$182.98K | SELL | -21.53% | 17.63K | Jan 04 - Jan 05 | ||
Jan 06, 2023 | PRESIDENT AND CEO | -6.67K | $37.21 | -$248.30K | SELL | -0.80% | 825.24K | Jan 04 | ||
Jan 06, 2023 | EVP, CHIEF BUSINESS OFFICER | -1.81K | $37.21 | -$67.42K | SELL | -9.48% | 17.31K | Jan 04 | ||
Jan 06, 2023 | EVP, CHIEF MEDICAL OFFICER | -2.57K | $37.21 | -$95.78K | SELL | -9.11% | 25.69K | Jan 04 | ||
Jan 06, 2023 | EVP, CHIEF FINANCIAL OFFICER | -2.43K | $37.21 | -$90.31K | SELL | -13.61% | 15.40K | Jan 04 | ||
Jan 06, 2023 | EVP, CHIEF TECHNICAL OFFICER | -2.03K | $37.65 | -$76.36K | SELL | -12.29% | 14.47K | Jul 01 - Jan 04 | ||
Jan 06, 2023 | EVP, GENERAL COUNSEL | -1.14K | $37.21 | -$42.34K | SELL | -5.50% | 19.56K | Jan 04 | ||
Mar 04, 2022 | PRESIDENT AND CEO | 46.34K | $112.25 | -$279.85K | SELL-OPTIONS | 5.96% | 824.07K | Jan 01 - Mar 01 | ||
Mar 03, 2022 | EVP, CHIEF SCIENTIFIC OFFICER | 16.17K | $112.25 | -$128.86K | SELL-OPTIONS | 656.44% | 18.63K | Jan 01 - Mar 01 | ||
Mar 03, 2022 | EVP, CHIEF MEDICAL OFFICER | 15.95K | $112.24 | -$117.96K | SELL-OPTIONS | 181.56% | 24.74K | Jan 01 - Mar 01 | ||
Mar 03, 2022 | EVP, CHIEF FINANCIAL OFFICER | 14.77K | $112.24 | -$113.70K | SELL-OPTIONS | ∞ | 14.77K | Jan 01 - Mar 01 | ||
Nov 09, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $72.67 | -$288.25K | SELL-OPTIONS | 0.00% | 8.71K | Nov 05 | ||
Oct 15, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $70.53 | -$277.96K | SELL-OPTIONS | 0.00% | 8.71K | Oct 14 | ||
Oct 13, 2021 | DIRECTOR | 0.00 | $69.19 | -$251.80K | SELL-OPTIONS | 0.00% | 2.09K | Oct 11 | ||
Oct 07, 2021 | DIRECTOR | 0.00 | $74.68 | -$1.12M | SELL-OPTIONS | 0.00% | 2.09K | Oct 05 | ||
Sep 23, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $81.22 | -$329.26K | SELL-OPTIONS | 0.00% | 791.00 | Sep 21 | ||
Sep 09, 2021 | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $97.35 | -$576.41K | SELL-OPTIONS | 0.00% | 0.00 | Sep 07 | ||
Sep 01, 2021 | PRESIDENT AND CEO | 0.00 | $88.95 | -$17.45M | SELL-OPTIONS | 0.00% | 777.72K | Aug 30 - Sep 01 | ||
Sep 01, 2021 | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $84.42 | -$13.66M | SELL-OPTIONS | 0.00% | 2.39K | Aug 30 | ||
Sep 01, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $85.33 | -$349.01K | SELL-OPTIONS | 0.00% | 791.00 | Aug 30 | ||
Sep 01, 2021 | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $89.22 | -$4.21M | SELL-OPTIONS | 0.00% | 0.00 | Aug 30 - Aug 31 | ||
Aug 25, 2021 | PRESIDENT AND CEO | 0.00 | $82.71 | -$3.76M | SELL-OPTIONS | 0.00% | 777.72K | Aug 23 | ||
Aug 20, 2021 | PRESIDENT AND CEO | 0.00 | $82.34 | -$3.13M | SELL-OPTIONS | 0.00% | 777.72K | Aug 19 | ||
Aug 11, 2021 | EVP, CHIEF MEDICAL OFFICER | 0.00 | $88.34 | -$363.43K | SELL-OPTIONS | 0.00% | 791.00 | Aug 09 | ||
Aug 06, 2021 | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $75.82 | -$3.25M | SELL-OPTIONS | 0.00% | 2.39K | Aug 04 | ||
Aug 06, 2021 | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $85.16 | -$2.64M | SELL-OPTIONS | 0.00% | 0.00 | Aug 05 | ||
Jun 29, 2021 | DIRECTOR | -553.38K | $132.73 | -$73.45M | SELL | -98.22% | 10.00K | Jun 28 | ||
Jun 15, 2021 | DIRECTOR | -201.72K | $87.04 | -$17.56M | SELL | -26.37% | 563.38K | Jun 11 - Jun 14 | ||
Apr 30, 2021 | DIRECTOR | -4.51K | $85.43 | -$385.55K | SELL | -0.59% | 765.10K | Apr 29 | ||
Apr 28, 2021 | DIRECTOR | -342.96K | $85.96 | -$29.48M | SELL | -30.83% | 769.61K | Apr 26 - Apr 28 | ||
Apr 07, 2021 | DIRECTOR | -800.00 | $84.98 | -$67.98K | SELL | -0.07% | 1.11M | Apr 05 | ||
Apr 06, 2021 | DIRECTOR | 0.00 | $44.29 | -$568.40K | SELL-OPTIONS | 0.00% | 5.41K | Apr 05 | ||
Apr 02, 2021 | PRESIDENT AND CEO | 32.83K | $48.89 | -$2.19M | SELL-OPTIONS | 4.57% | 751.78K | Apr 01 | ||
Apr 02, 2021 | EVP, GENERAL COUNSEL | 46.55K | $47.49 | -$2.95M | SELL-OPTIONS | 12.31% | 424.60K | Apr 01 | ||
Mar 01, 2021 | DIRECTOR | -501.94K | $60.29 | -$30.26M | SELL | -31.07% | 1.11M | Feb 26 | ||
Feb 09, 2021 | EVP, GENERAL COUNSEL | 9.51K | $46.65 | -$477.48K | SELL-OPTIONS | 2.57% | 380.13K | Feb 09 | ||
Feb 09, 2021 | PRESIDENT AND CEO | 45.73K | $40.62 | -$2.73M | SELL-OPTIONS | 6.79% | 718.95K | Feb 05 - Feb 09 | ||
Feb 03, 2021 | PRESIDENT AND CEO | 139.31K | $41.21 | -$7.15M | SELL-OPTIONS | 26.09% | 673.22K | Feb 01 - Feb 03 | ||
Feb 03, 2021 | EVP, GENERAL COUNSEL | 54.34K | $36.84 | -$2.44M | SELL-OPTIONS | 17.18% | 370.62K | Feb 01 | ||
Jan 05, 2021 | PRESIDENT AND CEO | 8.14K | $55.86 | -$348.51K | SELL-OPTIONS | 1.55% | 533.90K | Dec 31 - Jan 05 | ||
Jan 05, 2021 | EVP, CHIEF OPERATING OFFICER | 3.42K | $55.86 | -$76.92K | SELL-OPTIONS | 25.79% | 16.66K | Dec 31 - Jan 05 | ||
Jan 05, 2021 | EVP, GENERAL COUNSEL | 2.71K | $55.86 | -$116.08K | SELL-OPTIONS | 0.87% | 314.20K | Dec 31 - Jan 05 | ||
Dec 18, 2020 | — | 0.00 | $36.00 | -$3.12M | OPTION EXERCISE | 0.00% | 5.00K | Dec 17 | ||
Dec 03, 2020 | — | 1.64K | $26.04 | -$59.13K | OPTION EXERCISE | 0.53% | 310.92K | Dec 01 | ||
Nov 27, 2020 | — | 0.00 | $27.37 | -$783.90K | OPTION EXERCISE | 0.00% | 525.77K | Nov 27 | ||
Nov 25, 2020 | — | 0.00 | $21.41 | -$1.46M | OPTION EXERCISE | 0.00% | 525.77K | Nov 25 | ||
Nov 18, 2020 | — | 0.00 | $24.29 | -$388.40K | OPTION EXERCISE | 0.00% | 525.77K | Nov 16 | ||
Nov 18, 2020 | — | 4.76K | $21.30 | -$134.47K | OPTION EXERCISE | 1.56% | 309.28K | Nov 16 - Nov 18 | ||
Nov 06, 2020 | — | 1.64K | $20.94 | -$24.79K | OPTION EXERCISE | 0.54% | 304.52K | Nov 04 | ||
Nov 06, 2020 | — | 0.00 | $16.41 | -$958.50K | OPTION EXERCISE | 0.00% | 525.77K | Nov 04 | ||
Oct 16, 2020 | — | 4.38K | $15.52 | -$67.58K | OPTION EXERCISE | 1.47% | 302.89K | Oct 15 | ||
Oct 09, 2020 | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Oct 07 | ||
Sep 17, 2020 | — | 4.38K | $13.93 | -$49.84K | OPTION EXERCISE | 1.49% | 298.50K | Sep 15 | ||
Sep 03, 2020 | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Sep 01 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.